Method of producing a recombinant microorganism

Patent metadata

Field	Value
Publication number	US-9315830-B2
Application number	US-201514608132-A
Country	US
Kind code	B2
Filing date	Jan 28, 2015
Priority date	Jan 28, 2014
Publication date	Apr 19, 2016
Grant date	Apr 19, 2016

Abstract

The invention provides a genetic tool to insert, replace, delete, or otherwise manipulate a nucleic acid sequence in a microorganism to produce a recombinant microorganism. Notably, the invention makes use of homologous recombination, a type of genetic recombination in which nucleotide sequences are exchanged between two similar or identical molecules of DNA. Since the invention involves three homologous recombination events, it is referred to as a “triple cross” method.

First claim

The invention claimed is:

1. A method of producing a recombinant microorganism, comprising:
(a) providing a microorganism comprising a genetic element comprising target nucleic acid T1, a target nucleic acid T2, and a target nucleic acid T3,
(b) providing a DNA construct comprising a left homology arm LHA1 homologous to T1, a right homology arm RHA1 homologous to T2, and a right homology arm RHA2 homologous to T3, wherein RHA2 is located between LHA1 and RHA1,
(c) allowing the genetic element of (a) to undergo homologous recombination with the DNA construct of (b), whereby T1 aligns with LHA1 and T2 aligns with RHA1 to insert the portion of the DNA construct between LHA1 and RHA1, including RHA2, into the genetic element between T1 and T2, and
(d) allowing the genetic element of (c) to undergo self-homologous recombination, whereby T3 aligns with RHA2 to remove the portion of the genetic element between T3 and RHA2.

2. The method of claim 1 , wherein the genetic element of (a) comprises 5′-T3-T1-T2-3′; the DNA construct of (b) comprises 5′-LHA1-RHA2-RHA1-3′; a microorganism comprising a genetic element comprising 5′-T3-T1-RHA2-T2-3′ is formed in (and a microorganism comprising a genetic element comprising 5′-T3-T2-3′ is formed in (d) such that T1 is deleted from the genetic element.

3. The method of claim 1 , wherein the genetic element of (a) comprises 5′-T3-T1-T2-3′; the DNA construct of (b) comprises 5′-LHA1-RHA2-IS1-RHA1-3′ wherein IS1 is an insertion nucleic acid; a microorganism comprising a genetic element comprising 5′-T3-T1-RHA2-IS1-T2-3′ is formed in (c); and a microorganism comprising a genetic element comprising 5′-T3-IS1-T2-3′ is formed in (d), such that T1 is replaced IS1 in the genetic, element.

4. The method of claim 1 , wherein the genetic element of (a) comprises 5′-T1 T3 -3-T4-T2-3′ wherein T1 encompasses T3 and T4 is a target nucleic acid; the DNA construct of (b) comprises 5′-LHA1 RHA2 -RHA2-RHA1-3 wherein LHA1 encompasses RHA2; a microorganism comprising a genetic element comprising 5′-T1 T3 -RHA2-T2-3′ is formed in (c); and a microorganism comprising a genetic element comprising 5′-T1 T3 -T2-3′ is formed in (d), such that T4 is deleted from the genetic element.

5. The method of claim 1 , wherein the genetic element of (a) comprises 5′-T1 T3 -T2-3′ wherein T1 encompasses T3; the DNA construct of (b) comprises 5′-LHA1 RHA2 -RHA2-IS1-RHA1-3′ wherein LHA1 encompasses RHA2 and IS1 is an insertion nucleic acid; a microorganism comprising a genetic element comprising 5′-T1 T3 -RHA2-IS1-T2-3′ is formed in (c); and a microorganism comprising a genetic element comprising 5′-T1 T3 -IS1-T2-3′ is formed in (d), such that IS 1 is inserted in the genetic element.

6. The method of claim 1 , wherein the genetic element of (a) comprises 5′-T1 T3 -T4-T2-3′ wherein T1 encompasses T3 and T4 is a target nucleic acid; the DNA construct of (b) comprises 5′-LHA1 RHA2 -RHA2-IS1-RHA1-3 wherein LHA1 encompasses RHA2 and IS1 is an insertion nucleic acid; a microorganism comprising a genetic element comprising 5′-T1 T3 -RHA2-IS1-T2-3′ is formed in (c); and a microorganism comprising a genetic element comprising 5′-T1 T3 -IS1-T2-3′ is formed in (d), such that T4 is replaced by IS1 in the genetic element.

7. The method of claim 1 , wherein the DNA construct of (b) further comprises a counter selection marker CS1 upstream of LHA1 and a positive selection marker PS1 and a counter selection marker CS2 between LHA1 and RHA2.

8. The method of claim 7 , wherein (c) is followed by a step of selecting for expression of PS1 and against expression of CS1 and (d) is followed by a step of selecting against expression of CS2.

9. The method of claim 7 , wherein CS1 and CS2 are independently selected from the group consisting of pheS*, upp, sacB, tetAR, thyA, ccdB, lacY, rpsL, codA, pyrE, HSTK (thiK) gatA-1, and mazF; and PS1 is selected from the group consisting of catP, tetA(C), tetM, aad9, aadA, aadA2, and ermB.

10. The method of claim 1 , wherein the DNA construct of (b) further comprises a counter selection marker CS1 upstream of LHA1 and a positive selection marker PS1 between LHA1 and RHA2.

11. The method of claim 10 , wherein is followed by a step of selecting for expression of PS1 and against expression of CS1.

12. The method of claim 10 , wherein CS1 is selected from the group consisting of pheS*, upp, sacB, tetAR, thyA, ccdB, lacY, rpsL, codA, pyrE, HSTK (thiK), gatA-1, and mazF; and PS1 is selected from the group consisting of catP, tetA(C), tetM, aad9, aadA, aadA2, and ermB.

13. The method of claim 1 , wherein LHA1 is longer than RHA2.

14. The method of claim 13 , wherein LHA1 is equal to or greater than about 1000 base pairs in length and RHA2 is equal to or less than about 300 base pairs in length.

15. The method of claim 1 , wherein LHA1 and RHA1 are each longer than RHA2.

16. The method of claim 15 , wherein LHA1 and RHA1 are each equal to or greater than about 1000 base pairs in length and RHA2 is equal to or less than about 300 base pairs in length.

17. The method of claim 1 , wherein the microorganism is a bacterium, archea, virus, or fungus.

18. The method of claim 1 , wherein the microorganism belongs to genus Clostridium, Acetobacterium, Moorella, Butyribacterium, Blautia, Oxobacter, Thermoanaerobacter, Escherichia, Klebsiella, Zymomonas, Citrobacter, Enterobacter, Salmonella, Serratia, Lactobacillus, Lactococcus, Enterococcus, Pediococcus, Streptococcus, Saccharomyces, Pichia, Candida Hansenula, Yarrowia, Rhodotorula, Rhizopus, Trichosporon, Lipomyces, Aspergillus, trichoderma, Exophila, Mucor, Cladosporium, Phanerochaete, Cladiophilalophora, Paecilomyces, Scedosporium, Ophistoma, Bacillus, Oligotropha, Pseudomonas, Carbophilus, Hydrogenophaga, Mycobacterium, Zavarzinia, Cupravidus, Senechocystis, Chloroflexus, Methylomonas, Methylobacter, Methylococcus, Methylomicrobium, Methylosphera, Methylocaldum, Methylocystis, Methylosinus, Methanobacterium, Methanococcus, Methanogenium, Methanosarcina, Methanoshera, Methanothermobacter, Methanotrix, Corynebacterium, Acinetobacter, Actinomyces, Bacteroides, Burkholderia, Brevibacterium, Pyrococcus, Geobacter, Geobacillus, Paenibacillus, Mycobacterium, Rhodopseudomonas, Thermatoga, Thermoanaerobacter, Streptomyces, Rhodobacter, Rhodococcus, Peptococcus, Bifidobacterium, Propionibacterium, Fusobacterium, Campylobacter, Veillonella, Aquincola, Arthrobacter, Moraxella , or Psychrobacter.

Assignees

• Lanzatech New Zealand Ltd

Inventors

• Walker David Jeffrey Fraser
• Koepke Michael

Classifications

• C12N15/902 Primary

  using homologous recombination · CPC title

• C12N15/74

  Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora · CPC title

• C12N15/65

  using markers (enzymes used as markers C12N15/52) · CPC title